Cardiac rehabilitation

Dalal, Hasnain M; Doherty, Patrick; Taylor, Rod S

doi:10.1136/bmj.h5000

Cited by 369 publications

(385 citation statements)

References 55 publications

Supporting

Mentioning

370

Contrasting

Unclassified

Order By: Relevance

“…CR programmes generally include components of health education, advice on reducing cardiovascular risk, physical activity and stress management (Dalal et al, 2015). Evidence has shown CR to be a safe and effective intervention that reduces the risk of hospital admissions and improves the health-related quality of life (HRQOL) of the patient population (Anderson et al, 2017a).…”

Section: Evidence On Impact From Related Interventionsmentioning

confidence: 99%

Evaluating the impact of the Eastern Academic Health Science Network Transformation Support Unit

Yang¹,

Pollard²,

Garrod³

et al. 2018

View full text Add to dashboard Cite

RAND Europe is a not-for-profit organisation whose mission is to help improve policy and decision making through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.All rights reserved. No part of this book may be reproduced in any form by any electronic or mechanical means (including photocopying, recording, or information storage and retrieval) without permission in writing from the European Commission. Published by the RAND Corporation, Santa Monica, Calif., and Cambridge, UK Support RAND

show abstract

Section: Evidence On Impact From Related Interventionsmentioning

confidence: 99%

Evaluating the impact of the Eastern Academic Health Science Network Transformation Support Unit

Yang¹,

Pollard²,

Garrod³

et al. 2018

View full text Add to dashboard Cite

show abstract

“…27 Other factors, which hinder attendance, include lack of social support, poor psychological wellbeing, inconvenient location with transport difficulties, competing work commitments and financial cost. 16 Inadequacies and time constraints related to education and counselling of patients before they leave hospital lead to deficiencies in implementation of preventive care later on. Patients who have a clear understanding of their after-hospital care instructions are 30% less likely to be readmitted or to visit the emergency department than patients who lack this information.…”

Section: Patient-related Gapsmentioning

confidence: 99%

Challenges in secondary prevention after acute myocardial infarction: A call for action

Piepoli

Corrà²,

Dendale

et al. 2016

Eur J Prev Cardiolog

Self Cite

126

View full text Add to dashboard Cite

Worldwide, each year more than 7 million people experience myocardial infarction, in which one-year mortality rates are now in the range of 10%, but vary with patient characteristics. The consequences are even more dramatic: among patients who survive, 20% suffer a second cardiovascular event in the first year and approximately 50% of major coronary events occur in those with a previous hospital discharge diagnosis of ischaemic heart disease. The people behind these numbers spur this call for action. Prevention after myocardial infarction is crucial to reduce risk and suffering. Evidence-based interventions include optimal medical treatment with anti-platelets and statins, achievement of blood pressure, lipid and blood glucose targets, and appropriate lifestyle changes. The European Society of Cardiology and its constituent bodies are determined to embrace this challenge by developing a consensus document in which the existing gaps for secondary prevention strategies are reviewed. Effective interventions in relation to the patients, healthcare providers and healthcare systems are proposed and discussed. Finally, innovative strategies in hospital as well as in outpatient and long-term settings are endorsed.

show abstract

“…Meta-analyses of other interventions have certainly influenced guidelines and recommendations in the prevention of cardiovascular disease. 28,29 Examples are the systematic reviews that have evaluated the benefits of cardiac rehabilitation on cardiovascular mortality, morbidity, and quality of life. 30,31 Findings from systematic reviews and meta-analyses have also protected patients from harm.…”

Section: Can Meta-analyses Inform the Design Of Future Trials?mentioning

confidence: 99%

Meta-Analyses of Human Cell-Based Cardiac Regeneration Therapies

Martin‐Rendon

2016

Circulation Research

View full text Add to dashboard Cite

Controversies from basic science, discrepancies from clinical trials, and divergent results from meta-analyses have recently arisen in the field of cell therapies for cardiovascular repair and regeneration. Noticeably, there are almost as many systematic reviews and meta-analyses published as there are well-conducted clinical studies. But how do we disentangle the confusion they have raised? This article addresses why results obtained from systematic reviews and meta-analyses of human cell-based cardiac regeneration therapies are still valid to inform the design of future clinical trials. It also addresses how meta-analyses are not free from limitations and how important it is to assess the quality of the evidence and the quality of the systematic reviews and finally how stronger conclusions can be drawn when several pieces of evidence converge.

show abstract

Cardiac rehabilitation

Cited by 369 publications

References 55 publications

Evaluating the impact of the Eastern Academic Health Science Network Transformation Support Unit

Evaluating the impact of the Eastern Academic Health Science Network Transformation Support Unit

Challenges in secondary prevention after acute myocardial infarction: A call for action

Meta-Analyses of Human Cell-Based Cardiac Regeneration Therapies

Contact Info

Product

Resources

About